z-logo
open-access-imgOpen Access
Human liver apolipoprotein B-100 cDNA: complete nucleic acid and derived amino acid sequence.
Author(s) -
Simon W. Law,
Susan Grant,
Kayoko Higuchi,
Ashok V. Hospattankar,
Karl J. Lackner,
N Lee,
H. Bryan Brewer
Publication year - 1986
Publication title -
proceedings of the national academy of sciences of the united states of america
Language(s) - English
Resource type - Journals
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.83.21.8142
Subject(s) - apolipoprotein b , biochemistry , complementary dna , amino acid , peptide sequence , ldl receptor , biology , microbiology and biotechnology , lipoprotein , chemistry , gene , cholesterol
Human apolipoprotein B-100 (apoB-100), the ligand on low density lipoproteins that interacts with the low density lipoprotein receptor and initiates receptor-mediated endocytosis and low density lipoprotein catabolism, has been cloned, and the complete nucleic acid and derived amino acid sequences have been determined. ApoB-100 cDNAs were isolated from normal human liver cDNA libraries utilizing immunoscreening as well as filter hybridization with radiolabeled apoB-100 oligodeoxynucleotides. The apoB-100 mRNA is 14.1 kilobases long encoding a mature apoB-100 protein of 4536 amino acids with a calculated amino acid molecular weight of 512,723. ApoB-100 contains 20 potential glycosylation sites, and 12 of a total of 25 cysteine residues are located in the amino-terminal region of the apolipoprotein providing a potential globular structure of the amino terminus of the protein. ApoB-100 contains relatively few regions of amphipathic helices, but compared to other human apolipoproteins it is enriched in beta-structure. The delineation of the entire human apoB-100 sequence will now permit a detailed analysis of the conformation of the protein, the low density lipoprotein receptor binding domain(s), and the structural relationship between apoB-100 and apoB-48 and will provide the basis for the study of genetic defects in apoB-100 in patients with dyslipoproteinemias.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here